Hydroxyethyl starch-induced postoperative bleeding in cardiac surgery patients: More trials needed? [2] (multiple letters)

Chest

Volumn 126, Issue 1, 2004, Pages 311-312

  Wilkes, Mahlon M ^a   Navickis, Roberta J ^a   Avorn, Jerry ^b   Winkelmayer, Wolfgang ^b  

^a Hygeia Associates   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; HETASTARCH;

BLOOD TRANSFUSION; CLINICAL TRIAL; DRUG INDICATION; DRUG SAFETY; HEART SURGERY; HUMAN; LETTER; META ANALYSIS; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZATION; RISK ASSESSMENT; SURGICAL RISK; TREATMENT OUTCOME;

EID: 3242723496     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.126.1.311     Document Type: Letter

References (13)

1. J Avorn M Patel R Levin Hetastarch and bleeding complications after coronary artery surgery Chest 124 2003 1437 1442
2. ME Villarino SM Gordon C Valdon A cluster of severe postoperative bleeding following open heart surgery Infect Control Hosp Epidemiol 13 1992 282 287
3. JT Cope D Banks MC Mauney Intraoperative hetastarch infusion impairs hemostasis after cardiac operations Ann Thorac Surg 63 1997 78 82
4. LA Herwaldt SK Swartzendruber MB Edmond The epidemiology of hemorrhage related to cardiothoracic operations Infect Control Hosp Epidemiol 19 1998 9 16
5. EJ Keyser DA Latter JE Morin Pentastarch versus albumin in cardiopulmonary bypass prime: impact on blood loss J Card Surg 14 1999 279 286
6. JE Knutson JA Deering FW Hall Does intraoperative hetastarch administration increase blood loss and transfusion requirements after cardiac surgery? Anesth Analg 90 2000 801 807
7. MM Wilkes RJ Navickis WJ Sibbald Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a metaanalysis of postoperative bleeding Ann Thorac Surg 72 2001 527 533
8. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research. Proceedings of the Blood Products Advisory Committee 73rd Meeting Available at: http://www.fda.gov/OHRMS/DOCKETS/ac/02/transcripts/3867T2.doc Accessed June 15, 2004
9. Fanikos J. Clinical algorithm development for albumin use: case report. Presented at the 2002 American Society of Health-System Pharmacists Midyear Clinical Meeting, Atlanta, GA, December 10, 2002
10. WL Holman Invited commentary Ann Thorac Surg 72 2001 534
11. EM Gibney Albumin meta-analysis [letter] Ann Intern Med 135 2001 1008 1009
12. MM Wilkes RJ Navickis Patient survival after human albumin administration: a meta-analysis of randomized, controlled trials Ann Intern Med 135 2001 149 164
13. MM Wilkes RJ Navickis Albumin meta-analysis [letter] Ann Intern Med 135 2001 1009